FDA Inspection
Ajanta Pharma USA IncAjanta Pharma USA Inc – FDA Inspection, Jul 22, 2025
Record Details
This FDA Inspection record concerns Ajanta Pharma USA Inc, with an inspection on July 22, 2025, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 659b0944-41d5-43b5-a2ed-eb7d4abb5387
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1276284
- FDA center
- Human Drugs
- Project area
- Postmarketing Surveillance and Epidemiology: Human Drugs
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ajanta Pharma USA Inc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 4, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 17, 2016 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Ajanta Pharma USA Inc
- FDA Inspection 1049436 - 2018-04-04
- FDA Inspection 965140 - 2016-03-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.